📚 See the Olive Young, PharmaResearch and K-Beauty investment hub for the full thread across Olive Young’s listing status, CJ indirect exposure, Rejuran / PharmaResearch and APR / Medicube.

TL;DR

• Olive Young is not publicly traded. It is a private subsidiary of the CJ Group, formally CJ Olive Young Corp., which separated from CJ Olive Networks in 2019.
• The cleanest indirect proxy is CJ Corporation (000120.KS) — the holding company that owns roughly 51.2% of CJ Olive Young. The Lee family (chairman Lee Jay-hyun’s children) holds another ~22% directly, with the remainder held by financial investors after a 2021 pre-IPO round.
• CJ CheilJedang (097950.KS) is not a direct Olive Young play. It is the group’s food / bio business (Bibigo, lysine, methionine). The cross-link is “same group, different listed entity.”
• Olive Young’s IPO has been deferred at least twice (cancelled 2022; subsequent strategic review). As of April 2026 there is no confirmed listing date.
• For investors who want real K-beauty exposure (rather than a holdco-discounted slice), the better-aligned listed names are AmorePacific, LG H&H, Cosmax, Kolmar Korea, and selected ODM/brand specialists. Full framework below.

1. The Direct Answer

No, Olive Young is not listed on any stock exchange.

Search-engine queries like “is olive young publicly traded” or “olive young stock” land here for a structural reason — the company has the brand recognition of a public stock (Korea’s #1 H&B retailer, US Amazon expansion, viral on TikTok) but the legal status of a private subsidiary. Foreign retail investors looking for a ticker don’t find one and conclude either (a) “I’ll buy the parent” or (b) “I’ll buy a different K-beauty name.” Both paths have nuance.

Corporate identity:

2. Why the Question Keeps Coming Up

Olive Young grew from a domestic chain into a global K-beauty distribution platform in the post-COVID window:

• Domestic dominance after rivals (Lalavla / GS, Lohbs / Lotte) effectively exited Korea’s H&B chain category — Olive Young is now the de-facto national H&B utility.
• Inbound-tourist halo — the Myeongdong flagship became a mandatory stop for Chinese, Japanese, and Southeast Asian travelers; tax-refund volume surged.
• Cross-border digital channel — globalolive.young.co.kr ships to 150+ countries, and the brand actively cross-promotes on TikTok / Instagram in the US, Japan, Vietnam, and Indonesia.
• PB / exclusive-brand engine — Olive Young is no longer a pure retailer; it is also a brand incubator (e.g., wakemake, Bring Green, Round A’Round) and an exclusive-launch channel for emerging K-beauty brands wanting domestic shelf-test before global scale-up.

This is exactly the profile US / EU / SEA retail investors want to own. The friction: there is no Olive Young ticker.

3. The Cleanest Indirect Proxy: CJ Corporation (000120.KS)

CJ Corporation is the listed holding company at the top of the CJ Group. Its ownership in CJ Olive Young is the largest single block.

Approximate cap-table (publicly reported levels)

(Stake percentages are reported levels and have shifted with each capital event; the directional fact — CJ Corp majority + Lee-family meaningful, financial-investor float — is stable.)

What CJ Corp actually owns (beyond Olive Young)

CJ Corp is a holdco. Its NAV is the sum of stakes in:

• CJ CheilJedang (food / bio — Bibigo, fermented amino acids)
• CJ ENM (entertainment — TVING, Mnet, Studio Dragon)
• CJ Logistics
• CJ Olive Young (Korea’s #1 H&B)
• CJ Freshway (B2B food)
• Smaller affiliates

So owning CJ Corp gives you a holdco-discounted slice of Olive Young plus everything else. That is both the appeal and the limitation.

Holdco discount math (illustrative)

If you wanted only Olive Young exposure, CJ Corp gives you:

Effective Olive Young exposure per ₩ of CJ Corp
= CJ Corp ownership in OY (~51.2%)
  × your ownership in CJ Corp
  × (1 − holdco discount)

Korean holdcos historically trade at a 30–50% discount to NAV. So even if Olive Young’s standalone equity value rises, your CJ Corp share captures only a discounted portion. Conversely, when the market re-rates Korean holdcos (e.g., during a Value-Up or governance-reform cycle — see April 2026 “Korea Outperformance” backdrop), CJ Corp can outperform Olive Young’s underlying growth via discount compression.

4. Why CJ CheilJedang Is Not a Direct Olive Young Play

CJ CheilJedang (097950.KS) is the most-googled CJ-affiliate in English, partly because of Bibigo’s US grocery footprint. It is a separate listed entity with no operational tie to Olive Young.

If a search-engine result tells you “buy CJ CheilJedang to get Olive Young exposure,” that’s wrong. CheilJedang is a food + bioscience company with its own thesis (lysine pricing, Bibigo US, methionine cycle).

5. Olive Young IPO History — Why It Hasn’t Happened Yet

A short timeline:

• 2019 — CJ Olive Young separates from CJ Olive Networks via spin-off, becomes its own corporate entity.
• 2021 — Pre-IPO round closes; financial investors (Glenwood-led consortium reported) take a minority stake; valuation discussions reportedly in the ₩1.5–1.8T range at the time.
• 2022 — Olive Young files for KOSPI listing. The deal is withdrawn citing weak IPO market conditions and valuation gap.
• 2023–2024 — Reports surface periodically of strategic options including a block-sale of the Lee-family stake, an Olive Young secondary offering, or a renewed IPO timing window. Some reports mentioned Goldman Sachs as advisor on capital-structure options. None of these culminated in a confirmed listing.
• 2026 (current) — Olive Young remains private. Operating numbers continue to grow strongly (revenue past ₩4T-class, double-digit OPM range). No confirmed listing date.

Why the delay matters for investors

1. Valuation has likely moved up. The 2021 pre-IPO mark of ₩1.5–1.8T is dated. Every additional year of double-digit revenue + margin expansion lifts the implied IPO valuation, which expands CJ Corp’s NAV — but only realizes if the market re-rates the holdco.
2. Successor-generation ownership matters. Lee Sun-ho’s ~11% personal stake is non-trivial. Any future IPO + post-IPO secondary creates a path to family-wealth crystallization that is a structural incentive for CJ Group to push the listing eventually.
3. Korean Value-Up backdrop. With Korean governance reform and the broader 2026 re-rating story (KOSPI YTD strength, holdco discount compression), the window for Olive Young IPO has materially improved vs. the 2022 environment.

Implication: the right way to read CJ Corp today is “holdco that owns a yet-to-IPO crown-jewel asset that is roughly 50% bigger and structurally better-positioned than at the last failed IPO attempt.”

6. The Better-Aligned K-Beauty Listed Names

If your actual goal is K-beauty exposure rather than “Olive Young specifically,” you have cleaner options. Five buckets:

Bucket A — Brand Heavyweights

These are the legacy K-beauty incumbents. They give you direct premium-brand exposure without the holdco discount, but they also carry China-tourism beta that has been volatile.

Bucket B — Indie & Mass-Market Brands (Listed)

The indie / clinical-skincare crossover names tend to ride US + Japan TikTok cycles harder than the heritage brands.

Bucket C — ODM / Manufacturing Backbone

ODMs are often the purest K-beauty wave play — they manufacture for whoever wins the brand cycle, including Olive Young’s PB lines and indie brands sold on Olive Young shelves. Lower brand-risk, higher capacity-utilization sensitivity.

Bucket D — Brand-Holding via Strategic M&A

• COSRX — Acquired by Kolmar BNH (200130.KS) in 2021; Kolmar BNH is a listed proxy for the COSRX US-Amazon-bestseller story.
• Other selective brand acquisitions by listed Korean cosmetics groups occur regularly; track via DART filings.

Bucket E — Holdco Indirects (where Olive Young actually sits)

• CJ Corporation (000120.KS) — the Olive Young holdco proxy itself.

Quick decision framework

7. The Olive Young Operating Profile — Why the Asset Matters

For context on why Olive Young drives this much search-engine and investor interest, here is the operating shape (publicly reported / industry-tracked levels):

• Korean H&B market share — dominant; rivals Lalavla / Lohbs effectively exited the offline H&B chain category.
• Store count — well over 1,300 domestic stores including flagships.
• Online channel — Olive Young Online + globalolive.young.co.kr together represent a meaningful and growing share of total revenue.
• PB / exclusive brands — wakemake, Bring Green, Round A’Round, biome, and others are Olive Young-incubated and act as both shelf-anchor and margin lever.
• Inbound tourism — Olive Young Myeongdong-class flagships are top-3 retail destinations for inbound foreign visitors per multiple tourism boards.
• Revenue scale — past the ₩4T-class, with meaningful YoY growth in 2024–2025 cycles (industry-tracked).

In other words: this is an asset that, on its own, would already be one of the larger non-tech KOSPI listings if it were public. That’s the size of the unlisted block sitting inside CJ Corporation’s NAV.

8. Risks to the “Buy CJ Corp for Olive Young” Trade

This trade is not a free option. Specific risks:

1. Holdco discount stays wide. If Korean Value-Up momentum fades, holdco discounts can stay at 35–50% indefinitely, capping how much Olive Young value flows through to CJ Corp shareholders.
2. No IPO crystallization. Without a listing, Olive Young’s “marked” value remains an internal accounting figure. Public-market re-rating only happens with a public catalyst (IPO, large secondary, strategic spin-off).
3. CJ Corp’s other assets dilute. CJ ENM and CJ CheilJedang carry their own cyclical pressures (entertainment cycle, lysine pricing, fx). A bad year at the affiliate level can offset Olive Young’s accretion.
4. Family-stake overhang. Lee-family direct stakes in Olive Young (separate from CJ Corp’s stake) mean a future IPO has potential family-block secondary supply that markets may price in.
5. Inbound-tourism beta. Olive Young is structurally exposed to Chinese-visitor recovery; downside scenarios on Korea–China relations affect a real % of the asset’s growth.
6. Channel disruption. US TikTok / Amazon dynamics could either accelerate (if Olive Young’s globalolive channel scales) or threaten (if independent Korean brands route around Olive Young directly to Western retailers).

9. Final Read

The exact answer to “Is Olive Young publicly traded?” is: No, and the right follow-up question is what you’re actually trying to own.

• If you want Olive Young specifically, your only public route is CJ Corporation (000120.KS) — accept the holdco discount, track the IPO timeline, treat the position as a Value-Up + IPO-catalyst combo.
• If you want K-beauty as a wave, ignore the search-engine impulse to find an Olive Young ticker and instead build exposure through AmorePacific / LG H&H (brands), Cosmax / Kolmar Korea (ODMs), and Kolmar BNH / COSRX (US-Amazon-bestseller specific).
• If you want CJ Group exposure broadly (food, entertainment, logistics, beauty), CJ Corporation again is the single-ticker entry point.
• Avoid the common misconception that CJ CheilJedang gives you Olive Young exposure — it doesn’t.

The most underappreciated piece of this whole picture is that Olive Young is materially larger and more profitable than at the 2022 IPO attempt, while CJ Corporation’s holdco discount has not yet meaningfully closed. Whenever the next IPO window opens — whether 2026, 2027, or 2028 — the NAV recognition of Olive Young is a real event for CJ Corporation shareholders.

For now, the cleanest English-search answer is the one we started with: No, Olive Young is not publicly traded. The closest you can get is CJ Corporation (000120.KS).

Appendix — Evidence Tier

[Fact]

• CJ Olive Young is not listed on any stock exchange.
• CJ Olive Young was carved out from CJ Olive Networks in 2019.
• CJ Corporation is the controlling shareholder of CJ Olive Young.
• Lee Sun-ho and Lee Kyung-hoo (chairman Lee Jay-hyun’s children) hold direct minority stakes in CJ Olive Young.
• A KOSPI IPO filing for CJ Olive Young was withdrawn in 2022.
• CJ CheilJedang (097950.KS) is a separate listed entity, with food / bio operations, not a direct shareholder of CJ Olive Young.
• AmorePacific (090430.KS), LG H&H (051900.KS), Cosmax (192820.KS), Kolmar Korea (161890.KS), and Kolmar BNH (200130.KS) are listed.

[Inference]

• CJ Olive Young’s implied private valuation is materially above the 2022 attempted-IPO range, driven by post-COVID revenue and margin expansion.
• The Korean holdco discount on CJ Corporation has historically run 30–50%, capping how much Olive Young’s underlying value flows through to listed CJ Corp shareholders.
• A renewed IPO window for Olive Young — whether 2026, 2027, or later — would be a NAV-recognition catalyst for CJ Corp.
• ODMs (Cosmax, Kolmar Korea) capture K-beauty wave economics with lower single-brand risk than the heritage-brand names.

[Speculation]

• Lee Sun-ho’s direct ~11% stake in CJ Olive Young is a structural incentive for the family / group to eventually monetize via IPO + secondary.
• A successful Olive Young IPO at meaningfully higher valuation than 2022 could trigger holdco-discount compression at CJ Corp beyond what fundamental NAV math alone would justify.

[Blocked]

• Exact current cap-table of CJ Olive Young (latest financial-investor stake adjustments not always publicly disclosed in full).
• Any confirmed 2026 IPO filing date.
• Precise gross-margin and operating-margin levels of CJ Olive Young’s PB lines.

Disclaimer: For research and information purposes only. Not investment advice. Names cited are for analytical illustration; readers should perform their own due diligence and consult licensed advisors before any investment decision.